Transforming growth factor-beta 1 or ascorbic acid are able to differentiate Wharton's jelly mesenchymal stem cells towards a smooth muscle phenotype.

about

Transforming growth factor-beta 1 or ascorbic acid are able to differentiate Wharton's jelly mesenchymal stem cells towards a smooth muscle phenotype.

Item

http://www.wikidata.org/entity/Q46390874

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Transforming growth factor-bet ...... rds a smooth muscle phenotype.

@en

Transforming growth factor-bet ...... rds a smooth muscle phenotype.

@nl

type

Item

label

Transforming growth factor-bet ...... rds a smooth muscle phenotype.

@en

Transforming growth factor-bet ...... rds a smooth muscle phenotype.

@nl

prefLabel

Transforming growth factor-bet ...... rds a smooth muscle phenotype.

@en

Transforming growth factor-bet ...... rds a smooth muscle phenotype.

@nl

P1476

Transforming growth factor-bet ...... rds a smooth muscle phenotype.

@en

P2093

B Mesure

http://www.w3.org/2001/XMLSchema#string

P Menu

http://www.w3.org/2001/XMLSchema#string

S Huber-Villaume

http://www.w3.org/2001/XMLSchema#string

P2860

Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro.

Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endothelial cells.

Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2.

Signaling mechanisms that regulate smooth muscle cell differentiation.

Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?

Synthesis and biological evaluation of novel 2-heteroarylimino-1,3-thiazolidin-4-ones as potential anti-tumor agents.

NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor

Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage.

In-depth evaluation of commercially available human vascular smooth muscle cells phenotype: Implications for vascular tissue engineering.

Immunomodulation of endothelial differentiated mesenchymal stromal cells: impact on T and NK cells.

P304

S101-S105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/BME-171630

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Emilie Velot

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28372284

http://www.w3.org/2001/XMLSchema#string